MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Total Liabilities (Quarterly) : 65.00M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.00M |
| March 31, 2026 | 65.74M |
| December 31, 2025 | 86.10M |
| September 30, 2025 | 80.04M |
| June 30, 2025 | 74.48M |
| March 31, 2025 | 67.64M |
| December 31, 2024 | 70.81M |
| September 30, 2024 | 62.88M |
| June 30, 2024 | 62.14M |
| March 31, 2024 | 65.95M |
| December 31, 2023 | 96.33M |
| September 30, 2023 | 95.20M |
| June 30, 2023 | 96.55M |
| March 31, 2023 | 93.61M |
| December 31, 2022 | 96.92M |
| September 30, 2022 | 99.82M |
| June 30, 2022 | 89.78M |
| March 31, 2022 | 89.38M |
| December 31, 2021 | 95.35M |
| September 30, 2021 | 93.84M |
| June 30, 2021 | 101.79M |
| March 31, 2021 | 106.83M |
| December 31, 2020 | 110.61M |
| September 30, 2020 | 109.35M |
| June 30, 2020 | 128.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 128.57M |
| December 31, 2019 | 132.77M |
| September 30, 2019 | 139.69M |
| June 30, 2019 | 145.63M |
| March 31, 2019 | 69.09M |
| December 31, 2018 | 73.19M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 47.46M |
| September 30, 2017 | 36.24M |
| June 30, 2017 | 52.60M |
| March 31, 2017 | 59.46M |
| December 31, 2016 | 60.26M |
| September 30, 2016 | 58.39M |
| June 30, 2016 | 55.45M |
| March 31, 2016 | 62.98M |
| December 31, 2015 | 27.92M |
| September 30, 2015 | 25.40M |
| June 30, 2015 | 20.60M |
| March 31, 2015 | 19.70M |
| December 31, 2014 | 19.93M |
| September 30, 2014 | 16.06M |
| June 30, 2014 | 11.54M |
| March 31, 2014 | 11.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| ABVC BioPharma, Inc. | 7.131M |
| Enovis Corp. | 2.287B |
| Edwards Lifesciences Corp. | 3.142B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 281.00M |
| Shareholders Equity (Quarterly) | 216.00M |
| Debt to Equity Ratio | 0.0797 |
| Current Ratio | 5.334 |
| Net Debt Paydown Yield | 0.05% |